Table: RaQualia Pharma -2024 group forecast
Dec 13 (Reuters) -
RaQualia Pharma Inc
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2024 Dec 31, 2024
LATEST PREVIOUS
FORECAST FORECAST
Sales 3.14 4.54
Operating loss 234 mln 313 mln
Recurring loss 476 mln 290 mln
Net loss 584 mln 236 mln
EPS loss 26.76 yen 10.91 yen
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T